Fusion Pharmaceuticals Inc. Common Shares
FUSN
FUSN was delisted on the 3rd of June, 2024.
40 hedge funds and large institutions have $221M invested in Fusion Pharmaceuticals Inc. Common Shares in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
44% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 9
3% more funds holding
Funds holding: 39 → 40 (+1)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1% less capital invested
Capital invested by funds: $222M → $221M (-$1.14M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$7.21M |
| 2 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$657K |
| 3 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$365K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$356K |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$322K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$4.38M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$606K |
| 3 |
BlackRock
New York
|
-$472K |
| 4 |
ASP
Adams Street Partners
Chicago,
Illinois
|
-$218K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$144K |
FUSN Hedge Fund Activity: Q3 2021 in Review
40 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Fusion Pharmaceuticals Inc. Common Shares (FUSN) for Q3 2021, worth a combined $221M — down 0.51% from $222M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new FUSN positions and 4 closed out — a net gain of 2 holders — while 13 added to existing stakes and 9 trimmed.
The largest buyer was Federated Hermes, adding an estimated $7.21M. The largest seller was Perceptive Advisors, cutting an estimated $4.38M.
- 40 institutional investors held Fusion Pharmaceuticals Inc. Common Shares (FUSN) as of Q3 2021, up from 39 in Q2 2021.
- Funds reported $221M of Fusion Pharmaceuticals Inc. Common Shares stock for Q3 2021, down 0.51% quarter-over-quarter.
- 6 funds opened new Fusion Pharmaceuticals Inc. Common Shares positions in Q3 2021 and 4 closed out, a net change of +2 holders.
- The largest Fusion Pharmaceuticals Inc. Common Shares buyer in Q3 2021 was Federated Hermes, an estimated $7.21M added.
- The largest Fusion Pharmaceuticals Inc. Common Shares seller in Q3 2021 was Perceptive Advisors, an estimated $4.38M sold.
Based on aggregated 13F filings for Q3 2021.